Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon

This study has been completed.

Study NCT00048763 Information provided by Otsuka America Pharmaceutical

First Received: November 7, 2002 Last Updated: July 14, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	June 2003
Estimated Primary Completion Date:	No date given